肝硬化腹部手术患者改良医院衰弱风险评分
基于美国全国住院患者样本2016-2018年10714例肝硬化非移植腹部手术患者,采用logistic和Poisson回归分析医院衰弱风险评分(HFRS)与院内死亡和住院时长的关联,并用lasso回归筛选出12个最具预测力的ICD-10编码构建肝硬化-HFRS,其预测院内死亡的AUC为0.89,优于原HFRS的0.79(p<0.001)。
要点
- HFRS与肝硬化腹部手术患者院内死亡(OR=6.42)和住院时长(IRR=1.79)独立相关。
- 从109个HFRS编码中筛选12个构建肝硬化-HFRS,预测死亡AUC 0.89优于原版0.79。
- 肝硬化-HFRS更精准反映肝硬化手术患者共病模式,简化了原评分复杂度。
核心结论
- 109项HFRS与肝硬化腹部手术患者不良结局相关,但12项成分即可解释大部分死亡关联。
- 构建的肝硬化-HFRS对院内死亡预测准确性优于原HFRS(AUC 0.89 vs 0.79,p<0.001)。
研究设计与样本
- 回顾性队列研究,数据来自美国全国住院患者样本(National Inpatient Sample)2016-2018年。
- 纳入10714例接受非移植腹部手术的成人肝硬化患者,中位年龄62岁,32%手术为择期。
主要发现
- HFRS与院内死亡风险升高相关(OR=6.42;95% CI: 4.93, 8.36)。
- HFRS与住院时长延长相关(IRR=1.79;95% CI: 1.72, 1.88)。
- lasso回归筛选出12个ICD-10编码,其预测死亡AUC为0.89,原109项HFRS为0.79(p<0.001)。
关键数值与推荐
- 肝硬化-HFRS包含12个ICD-10编码,预测院内死亡AUC=0.89(原HFRS AUC=0.79,p<0.001)。
- HFRS与院内死亡OR=6.42(95% CI: 4.93, 8.36),与住院时长IRR=1.79(95% CI: 1.72, 1.88)。
临床怎么用
- 肝硬化-HFRS可基于行政数据快速评估肝硬化腹部手术患者院内死亡风险。
- 简化评分较原109项HFRS更易操作,有助于围手术期风险分层。
局限性
- 研究基于行政数据集,可能存在编码偏倚和未测量混杂。
- 结论仅适用于非移植腹部手术的肝硬化住院患者,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Existing tools for perioperative risk stratification in patients with cirrhosis do not incorporate measures of comorbidity. The Hospital Frailty Risk Score (HFRS) is a widely used measure of comorbidity burden in administrative dataset analyses. However, it is not specific to patients with cirrhosis, and application of this index is limited by its complexity. APPROACH AND RESULTS: Adult patients with cirrhosis who underwent nontransplant abdominal operations were identified from the National Inpatient Sample, 2016-2018. Adjusted associations between HFRS and in-hospital mortality and length of stay were computed with logistic and Poisson regression. Lasso regularization was used to identify the components of the HFRS most predictive of mortality and develop a simplified index, the cirrhosis-HFRS. Of 10,714 patients with cirrhosis, the majority were male, the median age was 62 years, and 32% of operations were performed electively. HFRS was associated with an increased risk of both in-hospital mortality (OR=6.42; 95% CI: 4.93, 8.36) and length of stay (incidence rate ratio [IRR]=1.79; 95% CI: 1.72, 1.88), with adjustment. Using lasso, we found that a subset of 12 of the 109 ICD-10 codes within the HFRS resulted in superior prediction of mortality in this patient population (AUC = 0.89 vs. 0.79, p < 0.001). CONCLUSIONS: While the 109-component HFRS was associated with adverse surgical outcomes, 12 components accounted for much of the association between the HFRS and mortality. We developed the cirrhosis-HFRS, a tool that demonstrates superior predictive accuracy for in-hospital mortality and more precisely reflects the specific comorbidity pattern of hospitalized patients with cirrhosis undergoing general surgery procedures.
引用
- Calthorpe L, Chiou SH, Rubin J, et al. A modified Hospital Frailty Risk Score for patients with cirrhosis undergoing abdominal operations. Hepatology. 2024. PMID: 38373139. doi:10.1097/HEP.0000000000000794
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。